Screening value of N-terminal pro-B-type natriuretic peptide as a predictor of perioperative cardiac events after noncardiac surgery

Future Cardiology

Volumn 6, Issue 5, 2010, Pages 603-609

  Goei, Dustin ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

cardiac risk assessment; noncardiac surgery; NT proBNP; perioperative cardiac events

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; CREATININE; DOBUTAMINE;

AGE; AMINO TERMINAL SEQUENCE; ANEMIA; AORTA VALVE STENOSIS; CARDIAC PATIENT; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; GENDER; HEART DEATH; HEART FUNCTION TEST; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HUMAN; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; MYOCARDIAL PERFUSION IMAGING; OBESITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT; SCREENING; SURGICAL RISK;

AGE FACTORS; ANEMIA; CARDIOVASCULAR DISEASES; GENERAL SURGERY; HUMANS; INTRAOPERATIVE COMPLICATIONS; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; OBESITY; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 77958053237     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.10.78     Document Type: Review

References (50)

1. Weiser TG, Regenbogen SE, Thompson KD et al.: An estimation of the global volume of surgery: A modelling strategy based on available data. Lancet 372(9633), 139-144 (2008).
2. Mangano DT, Goldman L: Preoperative assessment of patients with known or suspected coronary disease. N. Engl. J. Med. 333(26), 1750-1756 (1995).
3. Boersma E, Poldermans D, Bax JJ et al.: Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and b-blocker therapy. JAMA 285(14), 1865-1873 (2001).
4. Halm EA, Browner WS, Tubau JF, Tateo IM, Mangano DT: Echocardiography for assessing cardiac risk in patients having noncardiac surgery. Study of perioperative ischemia research group. Ann. Intern. Med. 125(6), 433-441 (1996).
5. Kertai MD, Bountioukos M, Boersma E et al.: Aortic stenosis: An underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am. J. Med. 116(1), 8-13 (2004).
6. Lainchbury JG, Campbell E, Frampton CM, Yandle TG, Nicholls MG, Richards AM: Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J. Am. Coll. Cardiol. 42(4), 728-735 (2003).
7. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A: N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110(15), 2168-2174 (2004).
8. Schnabel R, Rupprecht HJ, Lackner KJ et al.: Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: Results from the atherogene study. Eur. Heart. J. 26(3), 241-249 (2005).
9. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R: N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N. Engl. J. Med. 352(7), 666-675 (2005). (Pubitemid 40239214)
10. Yeh HM, Lau HP, Lin JM, Sun WZ, Wang MJ, Lai LP: Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery. Br. J. Surg. 92(8), 1041-1045 (2005). One of the first observational studies in which preoperative plasma levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) were evaluated to predict cardiac complications in patients undergoing noncardiac surgery.
11. Feringa Hh, Bax JJ, Elhendy A et al.: Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. Am. J. Cardiol. 98(1), 111-115 (2006).
12. Dernellis J, Panaretou M: Assessment of cardiac risk before non-cardiac surgery: Brain natriuretic peptide in 1590 patients. Heart 92(11), 1645-1650 (2006).
13. Schouten O, Hoeks Se, Goei D, Bax JJ, Verhagen HJ, Poldermans D: Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery. J. Vasc. Surg. 49(2), 435-441; discussion 441-1432 (2009). Assessed the additional prognostic value of NT-proBNP levels as a simple objective risk marker for postoperative cardiac events among vascular surgery patients.
14. Choi JH, Cho DK, Song YB et al.: Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in non-cardiac surgery. Heart 96(1), 56-62 (2010).
15. Bolliger D, Seeberger MD, Filipovic M: Pre-operative cardiac risk assessment in noncardiac surgery: Are natriuretic peptides the magic bullet? J. Am. Coll. Cardiol. 54(17), 1607-1608 (2009).
16. Goldman L, Caldera Dl, Nussbaum SR et al.: Multifactorial index of cardiac risk in noncardiac surgical procedures. N. Engl. J. Med. 297(16), 845-850 (1977).
17. Detsky AS, Abrams HB, Mclaughlin JR et al.: Predicting cardiac complications in patients undergoing non-cardiac surgery. J. Gen. Intern. Med. 1(4), 211-219 (1986).
18. Eagle KA, Coley CM, Newell JB et al.: Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann. Intern. Med. 110(11), 859-866 (1989).
19. Gilbert K, Larocque BJ, Patrick LT: Prospective evaluation of cardiac risk indices for patients undergoing noncardiac surgery. Ann. Intern. Med. 133(5), 356-359 (2000).
20. Lee TH, Marcantonio ER, Mangione CM et al.: Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100(10), 1043-1049 (1999).
21. Boersma E, Kertai MD, Schouten O et al.: Perioperative cardiovascular mortality in noncardiac surgery: Validation of the Lee cardiac risk index. Am. J. Med. 118(10), 1134-1141 (2005). Use of an adapted index, as augmented by age and more detailed classification of type of surgery, is a promising option to improve the Lee cardiac risk index.
22. Mantha S, Roizen MF, Barnard J, Thisted RA, Ellis JE, Foss J: Relative effectiveness of four preoperative tests for predicting adverse cardiac outcomes after vascular surgery: A meta-analysis. Anesth. Analg. 79(3), 422-433 (1994).
23. Shaw LJ, Eagle KA, Gersh BJ, Miller DD: Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. J. Am. Coll. Cardiol. 27(4), 787-798 (1996).
24. Kertai MD, Boersma E, Bax JJ et al.: A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 89(11), 1327-1334 (2003).
25. Kertai MD, Boersma E, Sicari R et al.: Which stress test is superior for perioperative cardiac risk stratification in patients undergoing major vascular surgery? Eur. J. Vasc. Endovasc. Surg. 24(3), 222-229 (2002).
26. Fleisher LA, Beckman JA, Brown KA et al.: 2009 ACCF/AHA focused update on perioperative b-blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J. Am. Coll. Cardiol. 54(22), E13-E18 (2009). Latest edition of the Americal College of Cardiology/Americal Heart Association guidelines.
27. De Lemos JA, Morrow DA, Bentley JH et al.: The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N. Engl. J. Med. 345(14), 1014-1021 (2001).
28. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N. Engl. J. Med. 339(5), 321-328 (1998). Review article on natriuretic peptides.
29. Hall C: Essential biochemistry and physiology of (NT-pro)BNP. Eur J. Heart Fail. 6(3), 257-260 (2004).
30. Yoshimura M, Yasue H, Okumura K et al.: Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 87(2), 464-469 (1993).
31. Yasue H, Yoshimura M, Sumida H et al.: Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90(1), 195-203 (1994).
32. Goei D, Hoeks SE, Boersma E et al.: Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients. Coron. Artery Dis. 20(3), 219-224 (2009).
33. Goei D, Flu WJ, Hoeks Se et al.: The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: The effect on predicting postoperative cardiac outcome in vascular surgery patients. Anesth. Analg. 109(5), 1403-1408 (2009).
34. Rodseth RN, Padayachee L, Biccard BM: A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 63(11), 1226-1233 (2008). First meta-analysis showing that NT-proBNP is a useful preoperative prognostic test in vascular surgical patients.
35. Karthikeyan G, Moncur RA, Levine O et al.: Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J. Am. Coll. Cardiol. 54(17), 1599-1606 (2009).
36. Ryding AD, Kumar S, Worthington AM, Burgess D: Prognostic value of brain natriuretic peptide in noncardiac surgery: A meta-analysis. Anesthesiology 111(2), 311-319 (2009). Recent meta-analysis showing that NT-proBNP is a useful preoperative prognostic test in patients undergoing noncardiac surgery.
37. Mahla E, Baumann A, Rehak P et al.: N-terminal pro-brain natriuretic peptide identifies patients at high risk for adverse cardiac outcome after vascular surgery. Anesthesiology 106(6), 1088-1095 (2007).
38. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr: Plasma brain natriuretic peptide concentration: Impact of age and gender. J. Am. Coll Cardiol 40(5), 976-982 (2002).
39. Frankenstein L, Clark AL, Goode K et al.: The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age. Heart 95(10), 825-829 (2009).
40. Di Angelantonio E, Chowdhury R, Sarwar N et al.: B-type natriuretic peptides and cardiovascular risk: Systematic review and meta-analysis of 40 prospective studies. Circulation 120(22), 2177-2187 (2009).
41. Goei D, Schouten O, Boersma E et al.: Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery. Am. J. Cardiol. 101(1), 122-126 (2008).
42. Ralli S, Horwich TB, Fonarow GC: Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure. Am. Heart J. 150(6), 1220-1227 (2005).
43. Wu AH, Omland T, Wold Knudsen C et al.: Relationship of B-type natriuretic peptide and anemia in patients with and without heart failure: A substudy from the breathing not properly (BNP) multinational study. Am. J. Hematol. 80(3), 174-180 (2005). (Pubitemid 41579538)
44. Dunkelgrun M, Hoeks SE, Welten GM et al.: Anemia as an independent predictor of perioperative and long-term cardiovascular outcome in patients scheduled for elective vascular surgery. Am. J. Cardiol. 101(8), 1196-1200 (2008).
45. Daniels LB, Clopton P, Bhalla V et al.: How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the breathing not properly multinational study. Am. Heart J. 151(5), 999-1005 (2006).
46. Frankenstein L, Remppis A, Nelles M et al.: Relation of N-terminal pro-brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status. Eur. Heart J. 29(21), 2634-2640 (2008).
47. Sarzani R, Dessi-Fulgheri P, Paci VM, Espinosa E, Rappelli A: Expression of natriuretic peptide receptors in human adipose and other tissues. J. Endocrinol. Invest. 19(9), 581-585 (1996).
48. Sengenes C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J: Natriuretic peptides: A new lipolytic pathway in human adipocytes. FASEB J 14(10), 1345-1351 (2000).
49. Morabito D, Vallotton MB, Lang U: Obesity is associated with impaired ventricular protein kinase C-map kinase signaling and altered ANP mRNA expression in the heart of adult zucker rats. J. Investig. Med. 49(4), 310-318 (2001).
50. Licata G, Volpe M, Scaglione R, Rubattu S: Salt-regulating hormones in young normotensive obese subjects. Effects of saline load. Hypertension 23(Suppl. 1), 20-24 (1994).